Regulation of cell proliferation using tissue engineering in MIN6 cells

Area of Science:

• Biotechnology
• Endocrinology
• Regenerative Medicine

Background:

• Pancreatic islet transplantation for diabetes mellitus faces donor organ shortages.
• Xenogenic cell lines, like murine MIN6 beta-cells, are explored as alternatives.
• Controlling proliferation of transplanted cells is crucial for safety and efficacy.

Purpose of the Study:

• To develop strategies for limiting the proliferation of transplanted MIN6 cells.
• To evaluate the functional capacity of modified MIN6 cell aggregates for diabetes treatment.
• To assess the viability and glucose responsiveness of encapsulated MIN6 spheroids.

Main Methods:

• MIN6 cells were cultured as spheroids (SMIN6) on nonadherent dishes to control proliferation.
• SMIN6 cells were further modified with extracellular matrix gel (SMIN6E).
• SMIN6E cells were encapsulated in agarose beads (SMIN6E-B) for in vitro assessment.

Main Results:

• SMIN6 spheroids ceased proliferation around day 7 and maintained size for at least 28 days.
• Standard SMIN6 spheroids exhibited reduced glucose-stimulated insulin secretion compared to monolayer cultures.
• SMIN6E spheroids demonstrated glucose-dependent insulin secretion comparable to conventional MIN6 cells.
• SMIN6E-B constructs remained viable for over a month with stable size and good glucose responsiveness.

Conclusions:

• Spheroid formation effectively controls MIN6 cell proliferation.
• Incorporating extracellular matrix gel enhances glucose responsiveness in MIN6 spheroids.
• Agarose encapsulation maintains viability and function of MIN6 spheroids.
• Spheroid-type MIN6 cells represent a promising avenue for future clinical applications in diabetes mellitus treatment.